Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.
about
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutationsIn vitro resistance profile of the candidate HIV-1 microbicide drug dapivirineHarnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings.Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
P2860
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Resistance mutations before an ...... re in HIV-1 infected patients.
@en
Resistance mutations before an ...... re in HIV-1 infected patients.
@nl
type
label
Resistance mutations before an ...... re in HIV-1 infected patients.
@en
Resistance mutations before an ...... re in HIV-1 infected patients.
@nl
prefLabel
Resistance mutations before an ...... re in HIV-1 infected patients.
@en
Resistance mutations before an ...... re in HIV-1 infected patients.
@nl
P2093
P356
P1476
Resistance mutations before an ...... re in HIV-1 infected patients.
@en
P2093
Anne Simon
Francoise Conan
Laurence Kalkias
Manuela Bonmarchand
Marc Wirden
Marc-Antoine Valantin
Myriam Kirstetter
Roland Tubiana
Vincent Calvez
P304
P356
10.1002/JMV.20359
P577
2005-07-01T00:00:00Z